X

Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

Medicare Part D cliff ahead

By Juliet Johnson  |    June 21, 2018
Medicare Part D has been providing seniors with access to prescription drug coverage that meets their needs for more than a decade. Today, more than 42 million people are enrolled in Part D and 90...   Read More

Part D cliff looms for seniors, as program stability could be in jeopardy

By Juliet Johnson  |    June 18, 2018
For more than a decade, Medicare Part D has successfully provided seniors comprehensive prescription drug coverage that meets their needs, while its market-based structure has kept overall program...   Read More

New “Let’s Talk About Medicare” campaign focuses on solutions to improve affordability and predictability for seniors in Part D

By Juliet Johnson  |    May 9, 2018
Today, we are launching the “Let’s Talk About Medicare” advertising campaign focused on solutions to improve affordability and predictability for seniors in Medicare Part D. Similar to how the “...   Read More

Medicare Monday: New Xcenda white paper looks at four strengths of Part B

By Nicole Longo  |    April 30, 2018
In case you missed it, a recent white paper from Xcenda took a deeper look at how Medicare Part B reimburses for physician-administered medicines and how the program has evolved over time. The...   Read More

Medicare Monday: Moran finds Part B medicine prices are stable, not a key driver of Medicare costs

By Nicole Longo  |    March 26, 2018
Earlier this year, we examined research that shows Part B spending continues to be a small, stable share of overall Medicare spending. Today, we’re looking at the trends in Average Sales Price...   Read More

Guess what? Part B drug spending remains stable share of Medicare spending

By Nicole Longo  |    January 23, 2018
Did you know that if you look at medicines in the pipeline for previously unmet medical needs, many are new and exciting immunotherapy treatments that are physician administered? That means these...   Read More

Medicare Monday: Helping beneficiaries access vaccines

By Nicole Longo  |    December 18, 2017
Last month, we released a State of Vaccines report, as well as an update to our Medicines in Development for Vaccines report, which shared exciting information about the 264 vaccines currently in...   Read More

Medicare Monday: Same bad ideas continue to threaten Part D and beneficiary access to medicines

By Nicole Longo  |    November 13, 2017
Perhaps the biggest fact that is often overlooked about Part D is that there is already significant price negotiation in the program. Thanks to Part D’s competitive structure, large purchasers...   Read More

Medicare Monday: CMS withdraws Part B demo, takes positive step forward on CMMI

By Nicole Longo  |    October 30, 2017
In case you missed it, earlier this month, the Center for Medicare & Medicaid Services formally withdrew a controversial proposal that would have had a detrimental impact on patient access to...   Read More

Medicare Monday: Open enrollment is here again

By Nicole Longo  |    October 16, 2017
It’s that time of year again: Medicare open enrollment! As of Sunday, October 15, newly qualified patients and current Medicare beneficiaries can review their coverage options and select their...   Read More

Search the Catalyst

View Posts by Topic

see all

Subscribe to Email Updates